Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subject with a confirmed diagnosis consistent with idiopathic generalized epilepsy experiencing primary generalized tonic-clonic seizures (IIE) that are classifiable according to the ILAE Classification of Epileptic Seizures.~* Presence of at least 3 PGTC seizures during the 8-week combined Baseline period.~* Absence of brain lesion documented on a CT scan or MRI.~* An EEG performed within 1 year of Visit 1 with features consistent with PGTC seizures or generalized idiopathic epilepsy.~* Male/female subject, \>=4 or \<=65 years of age at Visit 1.~* Subject on a stable dose of one or two AEDs during baseline.~Exclusion Criteria:~* Previous exposure to levetiracetam.~* History of partial seizures.~* History of convulsive or non-convulsive status epilepticus while taking concomitant AEDs within three months prior to Visit 1.

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 65 Years
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).